Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using anti-EGFR and anti-HER2 antibodies

Combination therapy using anti-EGFR and anti-HER2 antibodies

US Patent 9522956 · Granted Dec 20, 2016

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-müllerian inhibiting substance antibodies and uses thereof2025
Anti-PD-L1 antibodies2025
Bispecific antibodies targeting EGFR and HER22024
Bispecific antibodies targeting EGFR and HER22024
Humanized and de-immunized antibodies2024
Anti-PD-L1 and IL-2 cytokines2024
Light chain immunoglobulin fusion proteins and methods of use thereof2022
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in2022
Humanized antibodies2021
Anti-human-HER3 antibodies and uses thereof2021
Anti-human-HER3 antibodies and uses thereof2021
Anti-cancer antibodies with reduced complement fixation2020